- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 498/02 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
Patent holdings for IPC class C07D 498/02
Total number of patents in this class: 193
10-year publication summary
|
15
|
2
|
7
|
7
|
7
|
4
|
5
|
7
|
0
|
3
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4893 |
9 |
| Merck Sharp & Dohme LLC | 3741 |
6 |
| Boehringer Ingelheim International GmbH | 4648 |
4 |
| President and Fellows of Harvard College | 5976 |
4 |
| Alantos Pharmaceuticals Holding, Inc. | 13 |
4 |
| Dana-Farber Cancer Institute, Inc. | 2564 |
4 |
| Biosplice Therapeutics, Inc. | 171 |
4 |
| Abbvie Inc. | 1801 |
3 |
| Academia Sinica | 940 |
3 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 707 |
3 |
| Incyte Holdings Corporation | 660 |
3 |
| Nerviano Medical Sciences S.r.l. | 256 |
3 |
| Plexxikon Inc. | 150 |
3 |
| RespireRx Pharmaceuticals Inc | 10 |
3 |
| Rigel Pharmaceuticals, Inc. | 538 |
3 |
| vTv Therapeutics LLC | 151 |
3 |
| Vtvx Holdings I LLC | 25 |
3 |
| Cyclenium Pharma Inc. | 11 |
3 |
| S*BIO Pte Ltd. | 25 |
3 |
| Samsung Display Co., Ltd. | 34798 |
2 |
| Other owners | 120 |